Meeder Asset Management Inc Glaukos Corp Transaction History

Meeder Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$34.86 - $63.77 $662 - $1,211	-19 Reduced 67.86%	9 $0
Q1 2022 May 10, 2022	BUY	$44.33 - $57.82 $1,241 - $1,618	28 New	28 $2,000
Q1 2020 May 15, 2020	SELL	$25.53 - $70.14 $229 - $631	-9 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$54.18 - $65.64 $487 - $590	9 New	9 $0
Q3 2019 Oct 17, 2019	SELL	$58.58 - $83.91 $88,397 - $126,620	-1,509 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$63.59 - $78.71 $56,658 - $70,130	891 Added 144.17%	1,509 $114,000
Q1 2019 Apr 16, 2019	BUY	$50.75 - $80.54 $31,363 - $49,773	618 New	618 $48,000

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.